Back to Search
TAYLOR STEUBER, PHARM.D., BCPS
PHARM.D., BCPS
Pharmacotherapy Pharmacist
NPI: 1609226125Individual
Specialties, Licenses & Credentials
Pharmacotherapy PharmacistPrimary
Pharmacist — Pharmacotherapy
Code: 1835P1200X
26025559A(IN)
Research & Publications (20)
Serum markers for prostate cancer: a rational approach to the literature.
PMID 18243505·Eur Urol·2008
6-review
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
PMID 17185368·Clin Chem·2007
8-other
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
PMID 17205511·Int J Cancer·2007
8-other
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
PMID 16152616·Int J Cancer·2006
8-other
Low-latitude seasonality of Cretaceous temperatures in warm and cold episodes.
PMID 16251961·Nature·2005
7-preclinical
Partin Tables cannot accurately predict the pathological stage at radical prostatectomy.
PMID 18786800·Eur J Surg Oncol·2009
4-observational
Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.
PMID 19010520·Urology·2009
8-other
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
PMID 19143908·J Sex Med·2009
8-other
Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.
PMID 19233911·Clin Chem·2009
8-other
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
PMID 18499335·Eur Urol·2009
8-other
Current technique of open intrafascial nerve-sparing retropubic prostatectomy.
PMID 19501454·Eur Urol·2009
8-other
Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series.
PMID 18718699·Eur Urol·2009
8-other
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
PMID 18853417·Cancer·2008
8-other
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
PMID 17964070·Eur Urol·2008
8-other
Clinical significance of p53 alterations in surgically treated prostate cancers.
PMID 18552821·Mod Pathol·2008
8-other
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
PMID 18692880·Urology·2008
8-other
Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.
PMID 19047112·Clin Cancer Res·2008
8-other
Marked gene transcript level alterations occur early during radical prostatectomy.
PMID 17448597·Eur Urol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1701 N SENATE AVE
INDIANAPOLIS, IN 46202 - Phone
- (317) 962-2318
Quick Facts
- NPI
- 1609226125
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile